SPIMACO - Disclosures
SPIMACO’s subsidiary seals deal with Merck to manufacture type 2 diabetes meds in KSA
Argaam 19/11/2023
SPIMACO secures SAR 300 mln credit facility from BSF
Argaam 14/06/2023
SPIMACO board proposes 815,000 share buyback for LTIP
Argaam 11/06/2023
SPIMACO board recommends no dividend for 2022
Argaam 29/03/2023
SPIMACO signs SAR 900 mln credit facilities with SABB, Al Rajhi Bank
Argaam 29/12/2022
SPIMACO finalizes permits to occupy Riyadh administrative tower
Argaam 25/12/2022
SPIMACO set to launch revamped 5-year plan
Argaam 19/12/2022
SPIMACO signs credit facilities with 3 banks for SAR 1.26 bln
Argaam 29/08/2022
SPIMACO board plans 6% cash dividend for 2021
Argaam 24/03/2022
SPIMACO signs SAR 240 mln deal with Swiss firm to localize injection manufacturing
Argaam 17/01/2022
SPIMACO signs SAR 150 mln Murabaha agreement with Saudi EXIM Bank
Argaam 04/11/2021
SPIMACO announces legal measures for violations in subsidiary outside Saudi Arabia
Argaam 29/06/2021
SPIMACO shareholders approve 10% cash dividend for 2020
Argaam 31/05/2021
SPIMACO inks final agreement with Swiss pharma firm to locally manufacture immunosuppressive drug
Argaam 28/04/2021
SPIMACO plans 10% cash dividend for 2020
Argaam 23/03/2021
SPIMACO says fire erupted at warehouse of 51%-owned subsidiary
Argaam 24/01/2021
SPIMACO signs MoU with Johnson & Johnson subsidiary to transfer, nationalize pharma technology
Argaam 20/09/2020
SPIMACO to voluntary liquidate a subsidiary
Argaam 17/09/2020
SPIMACO sells part of equity investment portfolio for SAR 482 mln
Argaam 16/09/2020
SPIMACO says accumulated losses down to 19.13% of capital as of June 30
Argaam 18/08/2020
SPIMACO approves 5% cash dividend for FY2019
Argaam 17/05/2020
SPIMACO signs deal with Amgen to market a biotech medicine
Argaam 29/04/2020
SPIMACO board recommends 5% dividend for FY 2019
Argaam 31/03/2020
SPIMACO receives initial findings of its associate company’s fraud case
Argaam 08/12/2019
SPIMACO gets SAR 150 mln loan from SIDF to boost exports
Argaam 27/08/2019
SPIMACO appoints new chairman
Argaam 03/04/2019
SPIMACO approves 10% dividend for H2 2018
Argaam 03/04/2019
SPIMACO Egypt approves amending capital hike
Argaam 05/03/2019
SPIMACO recommends 10% dividend for H2 2018
Argaam 05/03/2019
SPIMACO refuses shareholder request to sack board of directors
Argaam 13/01/2019
SPIMACO approves Dammam Pharma's 50% capital hike
Argaam 27/12/2018
SPIMACO to discuss board dismissal, new audit committee in January
Argaam 27/11/2018
SPIMACO to move ops to Riyadh administrative tower by Q1 2019
Argaam 01/11/2018
SPIMACO signs SAR 189 mln contracts with health ministry
Argaam 03/09/2018
SPIMACO plans 5% dividend for H1 2018
Argaam 31/07/2018
SPIMACO to pump SAR 14.6 mln for SPIMACO Egypt’s capital hike
Argaam 03/05/2018
SPIMACO approves 10% dividend for FY17
Argaam 22/04/2018
SPIMACO shareholders to vote on 10% dividend Apr. 19
Argaam 03/04/2018
SPIMACO recommends 10% dividend for FY17
Argaam 22/03/2018
SPIMACO’s shareholders approve board rules, policies
Argaam 25/12/2017
SPIMACO’s Arac Healthcare to set up new SAR 5 mln subsidiary
Argaam 04/06/2015
SPIMACO greenlights $53.33 mln cancer treatment project
Argaam 04/06/2015
SPIMACO sells stake in EirGen Pharma for SAR 152.4 mln profit
Argaam 06/05/2015
SPIMACO to sell stake in foreign investment for SAR 150 mln profit
Argaam 04/05/2015
SPIMACO set to acquire 51% stake in Egypt’s Meivo
Argaam 04/05/2015
SPIMACO to issue 15% dividend for 2014
ِArgaam 26/04/2015
SPIMACO to up its stake in E-Pharma Morocco through capital raise
Argaam 26/04/2015
SPIMACO recommends 15% cash dividend for 2014
Argaam 17/02/2015
SPIMACO signs SAR 134m contract for the execution of its Dammam project
Argaam 29/09/2014
SPIMACO’s board approves 50% capital raise of its affiliate
Argaam 15/06/2014
Saudi Spimaco to increase capital of Arak Healthcare by 500 percent
Argaam 20/04/2014
SPIMACOADDWAEIH board recommends 52.98 % capital raise
Tadawul 23/02/2014
Saudi SPIMACO to build SAR 100 million office tower in Riyadh
Argaam 23/02/2014
SPIMACO restructures Dammam Pharma’s Capital:
Argaam 24/09/2013
SPIMACO establishes Dammam Pharma Company for SAR 120m:
Argaam 11/09/2012